At A Glance
1
Bristol Myers Squibb Co.
2
Revenue is primarily driven by Sales Revenue Gross (32.4%) and Net Product Sales (28.8%).
3
Most recently: as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein in its entirety. Other than the Earnings Press Release, the information (2026-02-05).
—
Market Cap
—
Revenue
—
Net Income
Employees34,100
Fundamentals
How The Business Makes Money
Revenue by Segment
Sales Revenue Gross32.4%($245.4B)
Net Product Sales28.8%($218.1B)
Legacy Brands9.7%($73.2B)
Growth Brands9%($68.3B)
Eliquis5.3%($40.0B)
Opdivo3.7%($28.4B)
Revlimid2%($14.8B)
Orencia1.5%($11.0B)
Pomalyst Imnovid1.3%($9.7B)
Yervoy1%($7.7B)
Reblozyl0.7%($5.1B)
Other Growth Brands0.6%($4.8B)
Alliance And Other Revenues0.6%($4.2B)
Sprycel0.5%($3.7B)
Alliance Revenues0.4%($3.1B)
Opdualag0.4%($2.7B)
Other Legacy Brands0.4%($2.7B)
Otherrevenues0.4%($2.7B)
Breyanzi0.3%($2.5B)
Abraxane0.3%($2.2B)
Camzyos0.3%($1.9B)
Zeposia0.2%($1.6B)
Abecma0.2%($1.3B)
Sotyktu0.1%($707M)
Krazati0%($331M)
Opdivo Ovantig0%($238M)
Cobenfy0%($165M)
Revenue by Geography
US69.7%($98.6B)
Non Us28.4%($40.1B)
Other Region2%($2.8B)
Activity